US2004067554A1PendingUtilityA1

Nucleotide sequences of moraxella catarrhalis genome

Priority: Jun 18, 1999Filed: Sep 26, 2003Published: Apr 8, 2004
Est. expiryJun 18, 2019(expired)· nominal 20-yr term from priority
C07K 14/212
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides the genomic sequences of a library of purified, polynucleotides, or their complements, comprising the genome of Moraxella catarrhalis . The invention also provides the identification of open reading frames contained within the polynucleotides of the library. The present invention further provides for the use of the polynucleotides, their complements or fragments, and proteins or portions thereof for identifying ligands and useful diagnostic and therapeutic compositions. In addition the invention provides for vectors, host cell sand methods for producing M. catarrhalis proteins or portions thereof.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A purified or isolated nucleic acid consisting essentially of a nucleotide sequence that encodes the same UDP-N-acetylmuramoylalanine-D-glutamate ligase encoded by nucleotides 11357 to 12736 of SEQ ID NO:35 or a nucleotide sequence fully complementary thereto.  
     
     
         2 . The purified or isolated nucleic acid of  claim 1 , wherein said nucleic acid sequence consists essentially of nucleotides 11357 to 12736 of SEQ ID NO:35 or a nucleotide sequence fully complementary thereto.  
     
     
         3 . A purified or isolated oligonucleotide consisting essentially of a fragment of a nucleic acid having the nucleotide sequence of nucleotides 11357 to 12736 of SEQ ID NO:35 or a sequence complementary thereto, wherein said oligonucleotide is at least 22 nucleotides in length.  
     
     
         4 . A recombinant construct comprising a nucleotide sequence that encodes the same UDP-N-acetylmuramoylalanine-D-glutamate ligase encoded by nucleotides 11357 to 12736 of SEQ ID NO:35, or a nucleotide sequence fully complementary thereto, operably linked to a promoter.  
     
     
         5 . A method of making UDP-N-acetylmuramoylalanine-D-glutamate ligase of  Moraxella catarrahalis  comprising: 
 obtaining a nucleic acid consisting essentially of a nucleotide sequence that encodes the same UDP-N-acetylmuramoylalanine-D-glutamate ligase encoded by nucleotides 11357 to 12736 of SEQ ID NO:35;    inserting said nucleic acid in an expression vector such that said nucleic acid is operably linked to a promoter; and    introducing said expression vector into a host cell whereby said host cell produces the protein encoded by said nucleic acid.    
     
     
         6 . The method of  claim 5 , further comprising isolating the protein.  
     
     
         7 . The method of  claim 5 , wherein said nucleic acid sequence consists essentially of nucleotides 11357 to 12736 of SEQ ID NO:35 or a nucleotide sequence fully complementary thereto.  
     
     
         8 . A method for constructing a host cell that expresses UDP-Nacetylmuramoylalanine-D-glutamate ligase of  Moraxella catarrahalis  comprising introducing a recombinant construct comprising a promoter operably linked to a nucleic acid comprising a nucleotide sequence that encodes the same UDP-N-acetylmuramoylalanine-D-glutamate ligase encoded by nucleotides 11357 to 12736 of SEQ ID NO:35 into said cell.  
     
     
         9 . The method of  claim 8 , wherein said nucleic acid sequence consists essentially of nucleotides 11357 to 12736 of SEQ ID NO:35 or a nucleotide sequence fully complementary thereto.  
     
     
         10 . A vector comprising the purified or isolated nucleic acid of  claim 1   
     
     
         11 . The vector of  claim 10 , wherein the isolated nucleic acid is operably linked to a promoter.  
     
     
         12 . The vector of  claim 11 , wherein the vector is an expression vector.  
     
     
         13 . A cultured cell line comprising the vector of  claim 10 .  
     
     
         14 . A vector comprising the purified or isolated nucleic acid of  claim 2 .  
     
     
         15 . The vector of  claim 14 , wherein the isolated nucleic acid is operably linked to a promoter.  
     
     
         16 . The vector of  claim 15 , wherein the vector is an expression vector.  
     
     
         17 . A cultured cell line comprising the vector of  claim 14 .  
     
     
         18 . An isolated expression construct comprising nucleotides 11357 to 12736 of SEQ ID NO:35, which encodes UDP-N-acetylmuramoylalanine-D-glutamate ligase, or a nucleotide sequence fully complementary thereto, operably linked to a promoter.  
     
     
         19 . A purified or isolated nucleic acid consisting essentially of a nucleic acid sequence which hybridizes under high stringency to nucleotides 11357 to 12736 of SEQ ID NO:35 and which encodes UDP-N-acetylmuramoylalanine-D-glutamate ligase.  
     
     
         20 . A purified or isolated nucleic acid which hybridizes substantially over the entire length to nucleotides 11357 to 12736 of SEQ ID NO:35 or a sequence complementary thereto under the following conditions: 5×SSC with 1% SDS at 60° C.; and washing with 0.2×SSC with 0.1% SDS at either 45 C or 68° C. or 0.5M sodium phospahate (pH 7.2), 7% SDS, and 1 mM EDTA at 65° C.; and washing with 40 mM sodium phosphate, 1% SDS, 1 mM EDTA at 65° C.

Join the waitlist — get patent alerts

Track US2004067554A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.